Abstract: Group C Streptococcus (GCS) is a rare cause of bacteremia in humans. It is mostly associated with zoonological infections. Although GCS can be part of the normal oral, skin, and genitourinary flora, an infection with this pathogen can be highly virulent, causing rapid, disseminating disease. With a mortality of about 25%, the poor prognosis is linked to the severity of illness and the high level of virulence of the organism. Only a few cases of GCS meningitis have been reported. We present the first case of GCS meningitis with cavernous sinus thrombosis. Keyword: streptococcus group C, cavernous sinus thrombosis, meningitis
/L. Basic metabolic profile was within normal limits, except for a potassium level of 3.2 meq/L, blood urea nitrogen of 44.9 mg/dL, and creatinine of 2.3 mg/dL. Chest X-ray revealed bilateral infiltrates in the middle and lower lung fields. Computed tomography (CT) of the head was unremarkable. The patient declined lumbar puncture. The blood culture grew penicillin sensitive Group C Streptococcus (GCS) within 24 hours of incubation. A few hours into the admission, he developed third and sixth nerve palsy. Further work-up revealed right cavernous and ophthalmic vein thrombosis on magnetic resonance imaging (Figures 1 and 2 ). Multiple patchy cavitary lesions on both lungs were seen in the chest CT. There was no vegetation on transesophageal echocardiogram. The oculomotor and abducens palsies resolved after medical management for 16 days. 
80
Clarke et al Discussion GCS is a rare cause of bacteremia, mostly associated with zoonological infections. [1] [2] [3] [4] [5] [6] [7] [8] It can cause a mucopurulent pulmonary disease in horses and mastitis in cattle. 2, 3 In humans, GCS can be part of the normal oral, skin, and genitourinary flora but, GCS infection can be highly virulent, causing rapid, disseminating disease [2] [3] [4] carrying with it a mortality of about 25%. 4, 5 The dismal prognosis is linked to the severity of illness and the high level of virulence of the organism. 2 This group of Streptococci can be differentiated from other species by their hemolysis pattern and their ability to ferment sorbitol and trehalose. 4 Examples of major species include Streptococcus equisimilis, S. zooepidemicus, S. equi, S. dysgalactiae, with the most common type isolated from the human throat being S. milleri. [1] [2] [3] [4] 6, 7 Unfortunately, one of our limitations was our laboratory was unable to identify the species of GCS. One study, which was based on the throat swabs of 1,016 college patients, showed that GCS was associated with pharyngitis.
3 This is significant concerning our patient as he had complained of symptoms of sore throat and had a tonsillar exudate.
Cases of virulent GCS infections are rare. GCS menigitis, though rare, has a strong association with patients who were in close contact with infected animals or consumed unpasterized milk.
1,2,6-9 Huang et al reported 13 cases of GCS meningitis; 2 of these cases, five died, four suffered permanent neurological sequelae of some kind, and four recovered without lasting sequelae. 2 To the best of our knowledge, ours is the first case of GCS meningitis with cavernous sinus thrombosis. Adverse outcomes can still occur despite timely initiation of appropriate antimicrobial treatment. 2, 4, 5 Blood cultures taken 24 hours after starting treatment would be negative, as well as cerebrospinal-fluid analysis. This expectionally rapid eradication rate of the pathogen exists in the presence of continued fever spikes and a worsening clinical picture, 2 as was the case for our patient. He continued to have symptoms of fever and chills for at least 7-10 days after starting treatment.
A classic presentation of meningitis includes nuchal rigidity, fever, headache, and photophobia. However, without aggressive treatment, patients can rapidly develop more severe signs such as tetraparesis, 9 aortic aneurysms, osteomyelitis and lymphadenitis, 5 hearing loss, and blindness.
2,4,5
A possible complication of meningitis can be the development of a thrombosis in the cavernous sinus. Cavernous sinus thrombosis is the formation of a blood clot within the cavernous sinus. This is a cavity at the base of the brain which drains deoxygenated blood from the brain back to the heart. The cause is usually from a spreading infection in the nose, sinuses, ears, or teeth. S. aureus and Streptococcus are often the culpable bacteria. Cavernous sinus thrombosis symptoms include: decrease or loss of vision, chemosis, exophthalmos, headaches, and paralysis of the cranial nerves that course through the cavernous sinus, features which were observed in our patient. This infection is life-threatening and requires 
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GCS infection is a rare cause of meningitis in humans. It has a high virulence and affected patients may suffer permanent neurologic sequela. Prior pharyngitis from this organism is an important risk factor. Oculomotor or abducens palsy in patients with meningitis further indicates thrombosis of the cavernous sinus since these nerves pass through the sinus.
To our knowledge we have presented the first case of GCS meningitis with cavernous sinus thrombosis.
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